Rejection antigens in chemically induced tumors.
作者信息
Klein G
机构信息
Microbiology and Tumor Biology Center, Karolinska Institute, 171 77 Stockholm, Sweden.
出版信息
Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):5991-2. doi: 10.1073/pnas.94.12.5991.
Abstract
摘要
相似文献
1
Rejection antigens in chemically induced tumors.
Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):5991-2. doi: 10.1073/pnas.94.12.5991.
2
Antigens of chemically induced tumors.
Exp Cell Biol. 1976;44(3-6):170-83. doi: 10.1159/000163110.
3
Mutated mitogen-activated protein kinase: a tumor rejection antigen of mouse sarcoma.
Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6375-9. doi: 10.1073/pnas.94.12.6375.
4
Failure of immunosurveillance against chemically induced in situ tumors in mice.
J Natl Cancer Inst. 1974 Mar;52(3):729-32. doi: 10.1093/jnci/52.3.729.
5
Rejection of normal and malignant tissue grafts by humoral antibodies.
Prog Clin Biol Res. 1983;133:243-9.
6
CD28 is not required for rejection of unmanipulated syngeneic and autologous tumors.
Eur J Immunol. 1997 Aug;27(8):1988-93. doi: 10.1002/eji.1830270824.
7
Toward a genetic analysis of tumor rejection antigens.
Adv Cancer Res. 1992;58:177-210. doi: 10.1016/s0065-230x(08)60295-x.
8
Allosensitization induced suppression of various murine tumors: role of non-H-2 antigens in antitumor immunity.
Indian J Exp Biol. 1990 Aug;28(8):706-10.
9
Apparent absence of virus-specific transplantation rejection antigen in herpes simplex virus-transformed hamster cells.
IARC Sci Publ (1971). 1978(24 Pt 2):905-10.
10
Demonstration of cross-reacting tumor rejection antigens in chemically induced respiratory tract carcinomas in rats.
Cancer Res. 1977 Nov;37(11):4059-63.
引用本文的文献
1
The messenger and the message: gp96 (GRP94)-peptide interactions in cellular immunity.
Cell Stress Chaperones. 2004 Winter;9(4):325-31. doi: 10.1379/csc-62.1.
本文引用的文献
1
TUMOR SPECIFIC IMMUNITY TO NONVIRAL TUMORS.
Proc Can Cancer Conf. 1963;5:387-95.
2
STUDIES ON SPECIFIC TRANSPLANTATION RESISTANCE TO POLYOMA-VIRUS-INDUCED TUMORS. IV. STABILITY OF THE POLYOMA CELL ANTIGEN.
J Natl Cancer Inst. 1964 Mar;32:661-6.
3
Mutated mitogen-activated protein kinase: a tumor rejection antigen of mouse sarcoma.
Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6375-9. doi: 10.1073/pnas.94.12.6375.
4
Loss of a unique tumor antigen by cytotoxic T lymphocyte immunoselection from a 3-methylcholanthrene-induced mouse sarcoma reveals secondary unique and shared antigens.
J Exp Med. 1996 Aug 1;184(2):441-7. doi: 10.1084/jem.184.2.441.
5
Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines.
J Exp Med. 1996 Apr 1;183(4):1357-65. doi: 10.1084/jem.183.4.1357.
6
7
A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma.
Science. 1995 Sep 1;269(5228):1281-4. doi: 10.1126/science.7652577.
8
9
Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutation.
Lancet. 1995 Nov 25;346(8987):1399-400. doi: 10.1016/s0140-6736(95)92408-6.
10
Systemic effects of methylcholanthrene in mice. II. Immune responses to sheep red cells.
Oncology. 1984;41(6):436-41. doi: 10.1159/000225872.
Zotero 插件